Literature DB >> 3538914

Paradoxical effects of amitriptyline on borderline patients.

P H Soloff, A George, R S Nathan, P M Schulz, J M Perel.   

Abstract

A paradoxical increase in suicide threats, paranoid ideation, and demanding and assaultive behavior occurred among 15 borderline inpatients receiving amitriptyline in a double-blind study. This pattern differed significantly from that of 14 nonresponding patients receiving placebo.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3538914     DOI： 10.1176/ajp.143.12.1603

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  6 in total

Review 1.  Aggression in borderline personality disorder.

Authors:  K Látalová; J Prasko
Journal:  Psychiatr Q       Date:  2010-09

2.  The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.

Authors:  S Kutcher; G Papatheodorou; S Reiter; D Gardner
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

Review 3.  Pharmacological interventions for borderline personality disorder.

Authors:  Jutta Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

Review 4.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

5.  Combined norepinephrine/serotonergic reuptake inhibition: effects on maternal behavior, aggression, and oxytocin in the rat.

Authors:  Elizabeth Thomas Cox; Thomas Merryfield Jarrett; Matthew Stephen McMurray; Kevin Greenhill; Vivian E Hofler; Sarah Kaye Williams; Paul Wayland Joyner; Christopher L Middleton; Cheryl H Walker; Josephine M Johns
Journal:  Front Psychiatry       Date:  2011-06-08       Impact factor: 4.157

6.  Psychopharmacologic treatment of borderline personality disorder.

Authors:  Luis H Ripoll
Journal:  Dialogues Clin Neurosci       Date:  2013-06       Impact factor: 5.986
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.